Frühmorgen P, Rufle W, Kobras S, Seeliger H, Herrmann G
Medizinische Klinik I, Schwerpunkt Gastroenterologie/Hepatologie, Klinikum Ludwigsburg, Germany.
Z Gastroenterol. 2003 Aug;41(8):703-10. doi: 10.1055/s-2003-41213.
In a prospective study initiated in 1982, we have been investigating the question as to whether - and if so, which - pT1 carcinomas of the colorectum can be treated exclusively via the endoscope.
In the period between February 1, 1982 and April 30, 2001, a total of 5,470 polyps were removed endoscopically at the Medical Department I of the Klinikum Ludwigsburg. Among these lesions, a total of 144 (2.6 %) pT1 carcinomas were found in 141 patients. We were able to follow 120 patients with 123 pT1 carcinomas over a mean follow-up period of 46 months (range: 1-60). In low-risk situations (definitive removal in healthy tissue, G1-G2, no lymphatic involvement), endoscopic treatment alone usually represented sufficient treatment. In high-risk cases (removal in healthy tissue uncertain or negative, and/or lymphatic vessel involvement, and/or G3/G4), subsequent surgical resection was carried out.
64 cases were classified as high-risk, 59 as low-risk. Nevertheless, 9 patients with 10 low-risk carcinomas were submitted to surgery (young age, patient's own request). In none of these 10 cases was residual tumour or lymph node metastasis detected in the surgical specimen. 47 patients with 49 low-risk carcinomas were treated solely by endoscopic polypectomy using the diathermy snare, and 45 patients with 47 carcinomas remained recurrence-free during the follow-up period. In a single case, a local recurrence was detected 2 months after polypectomy and underwent curative resection. In another case, peritoneal carcinosis with tumour infiltrating into the colon developed 8 months after initial treatment; this, however, was most probably a recurrence of a previously operated carcinoma of the uterus. Among the high-risk cases, 10 were not submitted to surgery on account of advanced age and/or rejection of an operation by the patient; all remained recurrence-free. Among the surgically treated high-risk carcinomas, 3 surgical specimens contained residual tumour, while 2 revealed a lymph node metastasis. In our group of patients, no tumour-related mortality was seen among endoscopically treated patients.
In the light of the fact that the reported mortality rate associated with open surgery for colorectal carcinoma is 3 % as compared with about 1 % risk of lymph node metastasis and 0,1 % mortality rate for the endoscopic modality, endoscopic removal of a pT1 tumour in a low-risk situation followed by appropriate surveillance can be considered as adequate treatment.
在1982年启动的一项前瞻性研究中,我们一直在研究一个问题,即结直肠的pT1期癌是否——如果是,哪些——可以仅通过内镜进行治疗。
在1982年2月1日至2001年4月30日期间,路德维希堡临床医院第一内科共通过内镜切除了5470个息肉。在这些病变中,141例患者共发现144个(2.6%)pT1期癌。我们能够对120例患有123个pT1期癌的患者进行平均46个月(范围:1 - 60个月)的随访。在低风险情况下(在健康组织中完全切除,G1 - G2级,无淋巴受累),单纯内镜治疗通常就代表足够的治疗。在高风险病例中(在健康组织中的切除不确定或为阴性,和/或淋巴管受累,和/或G3/G4级),随后进行手术切除。
64例被分类为高风险,59例为低风险。然而,9例患有10个低风险癌的患者接受了手术(年龄小,患者自己要求)。在这10例手术标本中,均未检测到残留肿瘤或淋巴结转移。47例患有49个低风险癌的患者仅通过电凝圈套器进行内镜息肉切除术治疗,45例患有47个癌的患者在随访期间无复发。在1例中,息肉切除术后2个月检测到局部复发并接受了根治性切除。在另1例中,初始治疗8个月后发生腹膜癌病,肿瘤浸润至结肠;然而,这很可能是先前手术切除的子宫癌的复发。在高风险病例中,10例因年龄较大和/或患者拒绝手术未接受手术;所有这些患者均无复发。在接受手术治疗的高风险癌中,3个手术标本含有残留肿瘤,2个显示有淋巴结转移。在我们的患者组中,内镜治疗的患者未出现与肿瘤相关的死亡。
鉴于报道的结直肠癌开放手术相关死亡率为3%,而内镜治疗的淋巴结转移风险约为1%,死亡率为0.1%,在低风险情况下内镜切除pT1期肿瘤并进行适当监测可被视为充分的治疗。